Zusammenfassung
Seit ihrer Einführung in den1980er-Jahren werden vollständig implantierbare zentralvenöse Zugänge bei Krebspatienten sehr häufig verwendet. Diese Systeme können bei langfristiger Chemotherapie und anderen Verfahren die Verabreichung erleichtern und den Patienten einige Unannehmlichkeiten ersparen. Obwohl erhebliche Unterschiede im Umgang mit diesen Ports bestehen, gibt es allgemein anerkannte Empfehlungen, die in der klinischen Praxis berücksichtigt werden sollten.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Bertoglio S et al. (2012) Efficacy of normal saline versus heparinized saline solution for locking catheters of totally implantable long-term central vascular access devices in adult cancer patients. Cancer Nurs 35 (4): 35–42
Camp-Sorrell D (ed) (2011) Access device guidelines: Recommendations for nursing practice and education. 3rd edn. Oncol Nursing Soc
Chaukiyal P et al. (2008) Thromboprophylaxis in cancer patients with central venous catheters. Thromb Haemost 99 (1): 38–43
Fernández-de-Maya J et al: (2013) Variability in management of implantable ports in oncology outpatients. Eur J of Oncol Nurs 17 (6): 835–840
Goossens GA et al (2013) Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Ann Oncol 24 ( 7): 1892–1899
Jordan K et al. (2008) Venous access ports: frequency and management of complications in oncology patients. Onkologie; 31 (7): 404–410
Ignatov A et al. (2010) Interval between port catheter flushing can be extended to four month. Gynecol Obstet Invest 70 (2): 91–94
Kulaylat MN et al. (2010) Regional treatment of colorectal liver metastasis. J Surg Oncol 101(8): 693–698
Lebeaux D et al. (2014) Management of infections related to totally implantable venous-access ports: challenges and perspectives. Lancet Infect Dis 14 (2): 146–159
Lewandowski RJ et al. (2011) Transcatheter intraarterial therapies: Rationale and overview. Radiology 259 (3): 641–657
Narducci F et al. (2011) Totally implantable venous access port systems and risk factors for complications:A one-year prospective study in a cancer centre. Eur J Surg Oncol 37 (10): 913–918
Teichgräber UK et al. (2011) Portsysteme als integraler Bestandteil von Chemotherapien. Deutsches Ärzteblatt 109 (9): 147–153
Zaghal A et al. (2012) Update on totally implantable venous access devices. Surg Oncol 21 (3): 207–215
Weiterführende Literatur
Camp-Sorrell D (2007) Clinical dilemmas: vascular access devices. Semin Oncol Nurs 23 (3): 232–239
Camp-Sorrell D (2010) State of the science of oncology vascular access devices. Semin Oncol Nurs 26 (2): 80–87
Chernecky C ed. (2010) Vascular access in oncology care. Semin Oncol Nurs 26 (2)
Xuying Li et al. (2015) Multifactor analysis of malposition of peripherally inserted central catheters in patients with cancer. Clin J Oncol Nurs 19 (4): E70-E73
Internet Adressen
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer-Verlag GmbH Deutschland
About this chapter
Cite this chapter
Klotz, H.P., Margulies, A. (2017). Implantierbare Port-Systeme und Pumpen. In: Margulies, A., Kroner, T., Gaisser, A., Bachmann-Mettler, I. (eds) Onkologische Krankenpflege. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-53955-2_14
Download citation
DOI: https://doi.org/10.1007/978-3-662-53955-2_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-53954-5
Online ISBN: 978-3-662-53955-2
eBook Packages: Medicine (German Language)